Among these agents, semaglutide and dulaglutide provide the most robust and high-certainty data, supported by large, well-designed RCTs showing significant reductions in major kidney outcomes and sustained preservation of kidney function
doi: 10.3390/nu9111175 517 SniffenJCMcFarlandLVEvansCTGoldsteinEJ
The shots may also be better for people seeking greater weight loss, Gibson added, because of their slower, more predictable absorption
IGF-1 DES exhibits moderate side effects, low oral and excellent subcutaneous bioavailability in mice
Serious reactions are uncommon, but anyone with allergies, medication concerns, or underlying medical conditions should discuss them with a medical provider first

Adults with longevity and biological aging optimization goals who want a foundational anti-aging intervention alongside other longevity peptides and lifestyle protocols Patients with age-related sleep deterioration and circadian rhythm disruption who have not responded adequately to standard sleep interventions Patients with documented age-related decline in multiple biological markers (antioxidant capacity, immune function, hormonal balance) for whom a broad-spectrum bioregulator approach is appropriate Patients already engaged in comprehensive longevity protocols (NMN, GH secretagogues, NAD+ optimization) who want to add a pineal-axis and telomere-focused component Patients over 45 to 50 where age-related biological decline provides the clinical rationale for a geroprotective intervention The cancer contraindication for Epitalon requires specific attention in the clinical assessment